Science & Enterprise subscription

Follow us on Twitter

  • An engineering team designed sensors that stick on the skin and form a network with radio-frequency signals to trac…
    about 19 hours ago
  • New post on Science and Enterprise: Skin Sensor Network Tracks Health Functions #Science #Business
    about 19 hours ago
  • A new project examines brain pathologies leading to development of Alzheimer's disease in Americans of Hispanic des…
    about 24 hours ago
  • New post on Science and Enterprise: Hispanic Neuro Disease Landscape Mapped in New Study #Science #Business
    about 24 hours ago
  • A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe…
    about 2 days ago

Please share Science & Enterprise

U.S. Patent Issued for Stem Cell Wound Care Technology

Stem Cells (NSF)

Stem Cells (National Science Foundation)

Stemedica Cell Technologies Inc. in San Diego has been granted a patent for its scaffolding technology based on adult stem cells used in healing wounds. Patent number 8,105,380 was awarded to Ludmilla and Alex Kharazi, Stemedica’s senior scientist and chief technology officer respectively, by the United States Patent and Trademark Office on 31 January 2012.

The patent covers Stemedica’s process for building a scaffold seeded with mesenchymal stem cells — those that transform into multiple cell types — and ectodermal or outer skin cells in a sandwich-like array. The scaffold provides a form for regenerating tissue, particularly for healing severely damaged tissue found in burns and wounds.

The company’s technology includes a biodegradable layer that enhances tissue growth and delivery of cytokines — proteins that encourage cell signaling and respond to infections — and a non-absorbable biological bandage layer that encourages closure of the broken skin. The scaffold is designed to mimic human skin and suitable for transplantation.

Stemedica is a licensed manufacturer of adult stem cells for pre-clinical research and clinical trials. The company is involved in a phase 1-2 clinical study of bone marrow stem cells to treat ischemic stroke, where blood to the brain is blocked. Stemedica is also conducting pre-clinical research in the use of neural stem cells to treat spinal cord injuries.

Read more:

*     *     *

Please share Science & Enterprise ...

2 comments to U.S. Patent Issued for Stem Cell Wound Care Technology